(1)
Ferrario, M.; Giuliani, G. [In Reference to "Clinical and Economic Evaluation of the Introduction of the Combinazion Trametinib + Dabrafenib in the Management of Advanced Melanoma in the Italian market”]. FE 2017, 18.